Corcept Therapeutics
CORT
CORT
135 hedge funds and large institutions have $664M invested in Corcept Therapeutics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 52 reducing their positions, and 22 closing their positions.
Holders
135
Holders Change
–
Holders Change %
0%
% of All Funds
3.37%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
28
Increased
37
Reduced
52
Closed
22
Calls
$1.97M
Puts
$224K
Net Calls
+$1.75M
Net Calls Change
+$858K
Top Buyers
Top Sellers
| 1 |
IA
1
Investor AB
Stockholm,
Sweden
|
$8.23M |
| 2 |
2
Two Sigma Investments
New York
|
$2.01M |
| 3 |
3
Morgan Stanley
New York
|
$14.4M |
| 4 |
ISL
4
Ingalls & Snyder LLC
New York
|
$86M |
| 5 |
5
D.E. Shaw & Co
New York
|
$2.5M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CF
151
Corrigan Financial
Middletown,
Rhode Island
| – | -$113K | -15,528 | Closed |
|
|
SCA
152
Secor Capital Advisors
New York
| – | -$107K | -14,784 | Closed |
|
153
HSBC Holdings
London,
United Kingdom
| – | -$93K | -12,868 | Closed |
|
154
ProShare Advisors
Bethesda,
Maryland
| – | -$87K | -11,999 | Closed |
|
|
SB
155
Suntrust Banks
Atlanta,
Georgia
| – | -$85K | -11,837 | Closed |
|
156
Balyasny Asset Management
Chicago,
Illinois
| – | -$85K | -11,704 | Closed |
|
|
SCM
157
Sitrin Capital Management
Century City,
California
| – | -$73K | -10,000 | Closed |
|